在儿科心力衰竭中,在左心室辅助装置之后,用于右心室衰竭的静脉输血前列环素
Laura J Radel1, Mehreen Iqbal1, Megan Griffiths1
1Division of Cardiology, Department of Paediatrics, University of Texas Southwestern, Dallas, TX, USA.
Cardiology in the young
|June 29, 2023
概括
在接受左心室辅助装置的儿童中,右心室衰竭可能是致命的. 静脉输入的前环素成功支持了这些患者,表明其作为这种并发症的关键治疗方法的潜力.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 心血管外科心血管外科
- 肺高血压是什么意思 肺高血压
背景情况:
- 右心室衰竭 (RVF) 是左心室辅助装置 (LVAD) 在儿科心力衰竭中植入后的一个显著并发症.
- 在这种情况下,RVF与死亡率的增加有关.
- 肺高血压 (PH) 往往伴随着LVAD放置后的RVF.
研究的目的:
- 报告静脉注射前列腺素在患有RVF和PH后LVAD植入的儿科患者的成功使用情况.
- 在LVAD支持的环境中,评估前列腺素作为RVF的治疗选择.
主要方法:
- 一个患有心力衰竭的儿科患者的病例报告,需要LVAD支持.
- 开始静脉注射前环素治疗RVF和PH.
- 监测右心室功能和肺动脉压力.
主要成果:
- 通过静脉注射前环素,成功实现了右心室支持.
- 肺高血压得到了有效的管理.
- 患者在干预后表现出改善的血液动力学稳定性.
结论:
- 静脉注射前列环素可以是一个有价值的治疗策略,用于管理右心室衰竭和肺高血压后LVAD植入儿科患者.
- 这种方法可能会改善高风险人群的结果.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
221
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
221
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
14
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
14
Venous Thrombosis III: Interprofessional Care
11
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11


